L
Lila Sciences
Scientific superintelligence to tackle humanity's greatest challenges through AI-driven discovery and innovation
At a glance
- Founded
- 2022
- Headquarters
- Cambridge, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Unicorn$1–10B valuation tier
Research & analysis
Latest news
Press, funding announcements and product moves mentioning Lila Sciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed8 investors entered at this stage
- MPModi Venture Partners
Flagship Pioneering
General Catalyst
ARK Invest- MPMarch Capital Partners
- BABlue Horizon Advisors
- AVAltitude Life Science Ventures
- SSState of Michigan Retirement Systems
Series A6 investors entered at this stage
- AFARK Venture Fund
- BRBraidwell
Alumni Ventures- NVNVentures
- CMCommon Metal
- NSNGS Super
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Lila Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Lila Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.